JPMorgan Chase & Co. Has $1.65 Million Stake in HealthStream, Inc. (NASDAQ:HSTM)

JPMorgan Chase & Co. lifted its holdings in shares of HealthStream, Inc. (NASDAQ:HSTM - Free Report) by 18.7% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 57,204 shares of the technology company's stock after buying an additional 9,017 shares during the period. JPMorgan Chase & Co. owned 0.19% of HealthStream worth $1,650,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Quarry LP acquired a new stake in shares of HealthStream in the third quarter valued at approximately $27,000. Point72 DIFC Ltd bought a new position in HealthStream in the 2nd quarter worth approximately $38,000. GAMMA Investing LLC increased its position in HealthStream by 36.0% in the 3rd quarter. GAMMA Investing LLC now owns 1,355 shares of the technology company's stock valued at $39,000 after acquiring an additional 359 shares during the period. Copeland Capital Management LLC bought a new stake in HealthStream during the 3rd quarter valued at $63,000. Finally, CWM LLC boosted its position in HealthStream by 64.2% during the 3rd quarter. CWM LLC now owns 4,448 shares of the technology company's stock worth $128,000 after acquiring an additional 1,739 shares during the period. Institutional investors and hedge funds own 69.58% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on HSTM shares. Canaccord Genuity Group raised their price target on HealthStream from $28.00 to $29.00 and gave the company a "hold" rating in a report on Wednesday, October 23rd. Barclays raised their target price on shares of HealthStream from $32.00 to $34.00 and gave the company an "overweight" rating in a research note on Wednesday, October 23rd. Finally, Craig Hallum raised shares of HealthStream to a "strong-buy" rating in a research note on Thursday, October 17th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, HealthStream has an average rating of "Buy" and a consensus target price of $31.50.

HealthStream Stock Up 0.3 %

HealthStream stock traded up $0.10 during midday trading on Thursday, hitting $32.16. The company's stock had a trading volume of 75,352 shares, compared to its average volume of 115,008. HealthStream, Inc. has a 12 month low of $23.92 and a 12 month high of $33.52. The company has a market capitalization of $978.31 million, a PE ratio of 49.48, a price-to-earnings-growth ratio of 4.15 and a beta of 0.40. The stock's 50-day moving average price is $32.06 and its 200-day moving average price is $30.08.

HealthStream (NASDAQ:HSTM - Get Free Report) last released its earnings results on Monday, October 21st. The technology company reported $0.19 EPS for the quarter, topping analysts' consensus estimates of $0.13 by $0.06. The business had revenue of $73.10 million for the quarter, compared to the consensus estimate of $73.53 million. HealthStream had a net margin of 6.84% and a return on equity of 5.67%. The business's revenue for the quarter was up 4.0% on a year-over-year basis. During the same period in the previous year, the firm earned $0.13 EPS. As a group, equities analysts anticipate that HealthStream, Inc. will post 0.63 EPS for the current year.

HealthStream Profile

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.